Multicenter comparison of analytical interferences of 25-OH vitamin D immunoassay and mass spectrometry methods by endogenous interferents and cross-reactivity with 3-epi-25-OH-vitamin D3
Joon Hee Lee , Jong Do Seo , Kyunghoon Lee , Eun Youn Roh , Yeo-Min Yun , Yong-Wha Lee , Sung-Eun Cho , Junghan Song
{"title":"Multicenter comparison of analytical interferences of 25-OH vitamin D immunoassay and mass spectrometry methods by endogenous interferents and cross-reactivity with 3-epi-25-OH-vitamin D3","authors":"Joon Hee Lee , Jong Do Seo , Kyunghoon Lee , Eun Youn Roh , Yeo-Min Yun , Yong-Wha Lee , Sung-Eun Cho , Junghan Song","doi":"10.1016/j.plabm.2023.e00347","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Vitamin D (vit-D) deficiency is highly prevalent in the Korean population, highlighting the need for accurate measurements. In this study, the interferences by endogenous and cross-reactive substances were compared between routine vit-D immunoassays and mass spectrometry (MS) methods.</p></div><div><h3>Methods</h3><p>Two MS methods and 4 immunoassays from different manufacturers (Abbott, Beckman Coulter, Roche, Siemens) were compared. Residual samples that were icteric, lipemic, hemolyzed, high in rheumatoid factor, from myeloma patients, or patients undergoing hemodialysis were collected. Also, 4 levels of National Institute of Standards and Technology (NIST) Standard Reference Material 972a, and 12 samples serially spiked with 3-epi-25-OH-D<sub>3</sub> were prepared.</p></div><div><h3>Results</h3><p>Significant interferences were observed in hemolytic (Roche), icteric (Beckman and Siemens) and lipemic samples (all 4 immunoassays). Level 4 NIST material and 3-epi-25-OH-D<sub>3</sub>-spiked samples induced significant cross-reactivity, yielding higher total vit-D measurements in non-epimer-separating MS methods, and both the Beckman and Roche immunoassays.</p></div><div><h3>Conclusion</h3><p>Most observed interferences were consistent with manufacturers’ claims, but overall improvement of immunoassay bias limits is required. Awareness of potential interference is important to increase the accuracy of vit-D measurements. Moreover, care is due when interpreting vit-D results of newborns, infants and less commonly, pregnant women, who are known to have physiologically high levels of the highly cross-reactive 3-epi-25-OH-D<sub>3</sub>.</p></div>","PeriodicalId":20421,"journal":{"name":"Practical Laboratory Medicine","volume":"38 ","pages":"Article e00347"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352551723000410/pdfft?md5=620057a5b6dc8e7ff9ad7905a61e4caf&pid=1-s2.0-S2352551723000410-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352551723000410","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Vitamin D (vit-D) deficiency is highly prevalent in the Korean population, highlighting the need for accurate measurements. In this study, the interferences by endogenous and cross-reactive substances were compared between routine vit-D immunoassays and mass spectrometry (MS) methods.
Methods
Two MS methods and 4 immunoassays from different manufacturers (Abbott, Beckman Coulter, Roche, Siemens) were compared. Residual samples that were icteric, lipemic, hemolyzed, high in rheumatoid factor, from myeloma patients, or patients undergoing hemodialysis were collected. Also, 4 levels of National Institute of Standards and Technology (NIST) Standard Reference Material 972a, and 12 samples serially spiked with 3-epi-25-OH-D3 were prepared.
Results
Significant interferences were observed in hemolytic (Roche), icteric (Beckman and Siemens) and lipemic samples (all 4 immunoassays). Level 4 NIST material and 3-epi-25-OH-D3-spiked samples induced significant cross-reactivity, yielding higher total vit-D measurements in non-epimer-separating MS methods, and both the Beckman and Roche immunoassays.
Conclusion
Most observed interferences were consistent with manufacturers’ claims, but overall improvement of immunoassay bias limits is required. Awareness of potential interference is important to increase the accuracy of vit-D measurements. Moreover, care is due when interpreting vit-D results of newborns, infants and less commonly, pregnant women, who are known to have physiologically high levels of the highly cross-reactive 3-epi-25-OH-D3.
多中心比较 25-OH 维生素 D 免疫测定法和质谱法受内源性干扰物的分析干扰以及与 3-epi-25-OH-vitamin D3 的交叉反应
背景维生素 D(vit-D)缺乏症在韩国人群中非常普遍,因此需要进行精确测量。本研究比较了常规维生素 D 免疫测定法和质谱法(MS)的内源性干扰和交叉反应物质。收集了来自骨髓瘤患者或血液透析患者的黄疸、脂血、溶血、类风湿因子含量高的残留样本。结果在溶血样本(罗氏)、黄疸样本(贝克曼和西门子)和脂血样本(所有 4 种免疫测定)中观察到明显的干扰。4 级 NIST 材料和 3-epi-25-OH-D3 加标样本会产生明显的交叉反应,从而导致非表聚分离 MS 方法以及贝克曼和罗氏免疫测定法测定的总维生素 D 值升高。认识到潜在的干扰对提高维生素 D 测量的准确性非常重要。此外,在解释新生儿、婴儿和孕妇的维生素 D 检测结果时也应小心谨慎,因为众所周知,孕妇体内的高交叉反应性 3-epi-25-OH-D3 水平很高。
期刊介绍:
Practical Laboratory Medicine is a high-quality, peer-reviewed, international open-access journal publishing original research, new methods and critical evaluations, case reports and short papers in the fields of clinical chemistry and laboratory medicine. The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics. We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.